Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A Beavis, Melissa A Henderson, Lauren Giuffrida, Jane K Mills, Kevin Sek, Ryan S Cross, Alexander J Davenport, Liza B John, Sherly Mardiana, Clare Y Slaney, Ricky W Johnstone, Joseph A Trapani, John Stagg, Sherene Loi, Lev Kats, David Gyorki, Michael H Kershaw, Phillip K Darcy
Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2017
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by Cancer Council Victoria Project Grant
Awarded by National Breast Cancer Foundation Fellowships
Awarded by NHMRC Senior Research Fellowships
The authors acknowledge the assistance of the Animal Facility technicians at the Peter MacCallum Cancer Centre. This work was funded by Project and Program grants from the National Health and Medical Research Council (NHMRC; APP1062580, APP1122444), a Cancer Council Victoria Project Grant (APP1084420), and a grant from the Peter MacCallum Cancer Centre Foundation. PAB and CYS are supported by National Breast Cancer Foundation Fellowships (ID nos. PF-14-008 and ECF-16-005). PKD and MHK are supported by NHMRC Senior Research Fellowships (APP1041828 and APP1058388, respectively). RWJ is supported by a Senior Principal Research Fellowship from the NHMRC.